| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 63,754,000 | 64.37% | ||
| 2 | Catabasis Pharmaceuticals Inc | 2,857,667 | 10,573,000 | 10.68% | ||
| 3 | OCULAR THERAPEUTIX INC | 1,932,607 | 9,566,000 | 9.66% | ||
| 4 | TRANSENTERIX INC | 7,546,692 | 9,207,000 | 9.30% | ||
| 5 | RAPTOR PHARMACEUTICAL CORP | 888,132 | 4,769,000 | 4.82% | ||
| 6 | LOMBARD MEDICAL INC | 1,077,499 | 1,174,000 | 1.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019508, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
